Literature DB >> 21127946

L-arabinose pathway engineering for arabitol-free xylitol production in Candida tropicalis.

Byoung Hoon Yoon1, Woo Young Jeon, Woo Yong Shim, Jung Hoe Kim.   

Abstract

Xylose reductase (XR) is a key enzyme in biological xylitol production, and most XRs have broad substrate specificities. During xylitol production from biomass hydrolysate, non-specific XRs can reduce L-arabinose, which is the second-most abundant hemicellulosic sugar, to the undesirable byproduct arabitol, which interferes with xylitol crystallization in downstream processing. To minimize the flux from L-arabinose to arabitol, the L-arabinose-preferring, endogenous XR was replaced by a D-xylose-preferring heterologous XR in Candida tropicalis. Then, Bacillus licheniformis araA and Escherichia coli araB and araD were codon-optimized and expressed functionally in C. tropicalis for the efficient assimilation of L-arabinose. During xylitol fermentation, the control strains BSXDH-3 and KNV converted 9.9 g L-arabinose l(-1) into 9.5 and 8.3 g arabitol l(-1), respectively, whereas the recombinant strain JY consumed 10.5 g L-arabinose l(-1) for cell growth without forming arabitol. Moreover, JY produced xylitol with 42 and 16% higher productivity than BSXDH-3 and KNV, respectively.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21127946     DOI: 10.1007/s10529-010-0487-2

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  2 in total

1.  Construction of plasmid-free Escherichia coli for the production of arabitol-free xylitol from corncob hemicellulosic hydrolysate.

Authors:  Buli Su; Zhe Zhang; Mianbin Wu; Jianping Lin; Lirong Yang
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

2.  Development of a promising microbial platform for the production of dicarboxylic acids from biorenewable resources.

Authors:  Heeseok Lee; Changpyo Han; Hyeok-Won Lee; Gyuyeon Park; Wooyoung Jeon; Jungoh Ahn; Hongweon Lee
Journal:  Biotechnol Biofuels       Date:  2018-11-09       Impact factor: 6.040

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.